89 related articles for article (PubMed ID: 21292868)
21. FRAX and its applications in health economics--cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example.
Ström O; Borgström F; Kleman M; McCloskey E; Odén A; Johansson H; Kanis JA
Bone; 2010 Aug; 47(2):430-7. PubMed ID: 20493983
[TBL] [Abstract][Full Text] [Related]
22. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density and bone loss measured at the radius to predict the risk of nonspinal osteoporotic fracture.
Gnudi S; Malavolta N; Lisi L; Ripamonti C
J Bone Miner Res; 2001 Jun; 16(6):1130-5. PubMed ID: 11393790
[TBL] [Abstract][Full Text] [Related]
24. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study.
McGrother CW; Donaldson MM; Clayton D; Abrams KR; Clarke M
Osteoporos Int; 2002 Jan; 13(1):89-96. PubMed ID: 11883411
[TBL] [Abstract][Full Text] [Related]
26. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
Hochberg MC; Thompson DE; Black DM; Quandt SA; Cauley J; Geusens P; Ross PD; Baran D;
J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
[TBL] [Abstract][Full Text] [Related]
27. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.
Stone KL; Seeley DG; Lui LY; Cauley JA; Ensrud K; Browner WS; Nevitt MC; Cummings SR;
J Bone Miner Res; 2003 Nov; 18(11):1947-54. PubMed ID: 14606506
[TBL] [Abstract][Full Text] [Related]
28. FRAX calculator and Garvan nomogram in male osteoporotic population.
Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Leszczynski P; Wichrowska H; Napiórkowska L; Stuss M; Ptaszek A; Kostyk T; Golba KS; Garbacz W; Drozdzowska B
Aging Male; 2014 Sep; 17(3):174-82. PubMed ID: 24456527
[TBL] [Abstract][Full Text] [Related]
29. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
[TBL] [Abstract][Full Text] [Related]
30. The utility of absolute risk prediction using FRAX® and Garvan Fracture Risk Calculator in daily practice.
van Geel TA; Eisman JA; Geusens PP; van den Bergh JP; Center JR; Dinant GJ
Maturitas; 2014 Feb; 77(2):174-9. PubMed ID: 24287178
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with 5-year risk of hip fracture in postmenopausal women.
Robbins J; Aragaki AK; Kooperberg C; Watts N; Wactawski-Wende J; Jackson RD; LeBoff MS; Lewis CE; Chen Z; Stefanick ML; Cauley J
JAMA; 2007 Nov; 298(20):2389-98. PubMed ID: 18042916
[TBL] [Abstract][Full Text] [Related]
32. Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women.
Leslie WD; Metge C; Ward L
Osteoporos Int; 2003 Jun; 14(4):334-8. PubMed ID: 12730741
[TBL] [Abstract][Full Text] [Related]
33. Reasons for discrepancies in hip fracture risk estimates using FRAX and Garvan calculators.
Billington EO; Gamble GD; Reid IR
Maturitas; 2016 Mar; 85():11-8. PubMed ID: 26857874
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram.
Sandhu SK; Nguyen ND; Center JR; Pocock NA; Eisman JA; Nguyen TV
Osteoporos Int; 2010 May; 21(5):863-71. PubMed ID: 19633880
[TBL] [Abstract][Full Text] [Related]
35. Intervals between bone density testing.
Reid IR; Gamble GD
J Bone Miner Res; 2014 Feb; 29(2):389-91. PubMed ID: 23893403
[TBL] [Abstract][Full Text] [Related]
36. Better bone density reporting: T-score report versus fracture risk report with outcome analysis.
Greenwald L; Barajas K; White-Greenwald M
Am J Manag Care; 2003 Oct; 9(10):665-70. PubMed ID: 14572176
[TBL] [Abstract][Full Text] [Related]
37. Overview of Fracture Prediction Tools.
Kanis JA; Harvey NC; Johansson H; Odén A; McCloskey EV; Leslie WD
J Clin Densitom; 2017; 20(3):444-450. PubMed ID: 28716500
[TBL] [Abstract][Full Text] [Related]
38. Five-year fracture risk assessment in postmenopausal women, using both the POL-RISK calculator and the Garvan nomogram: the Silesia Osteo Active Study.
Zagórski P; Tabor E; Martela-Tomaszek K; Adamczyk P; Pluskiewicz W
Arch Osteoporos; 2021 Feb; 16(1):32. PubMed ID: 33594643
[TBL] [Abstract][Full Text] [Related]
39. Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden.
Kanis JA; Johnell O; Oden A; Jonsson B; Dawson A; Dere W
Osteoporos Int; 2000; 11(2):120-7. PubMed ID: 10793869
[TBL] [Abstract][Full Text] [Related]
40. FRAX--Where are we now?
Compston J
Maturitas; 2015 Nov; 82(3):284-7. PubMed ID: 26277257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
